Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v10-FR Version v6-FR
Language French French
Date Updated 2017-12-20 2017-11-16
Drug Identification Number 02187078 02187078
Brand name HAVRIX - SUS IM 1440 ELISA UNITS/ML HAVRIX - SUS IM 1440 ELISA UNITS/ML
Common or Proper name hepatitis A vaccine, inactivated hepatitis A vaccine, inactivated
Company Name GLAXOSMITHKLINE INC GLAXOSMITHKLINE INC
Ingredients HEPATITIS A VACCINE, INACTIVATED HEPATITIS A VACCINE, INACTIVATED
Strength(s) 1440UNIT 1440UNIT
Dosage form(s) SUSPENSION SUSPENSION
Route of administration INTRAMUSCULAR INTRAMUSCULAR
Packaging size 1's (prefilled syringe) 1's (prefilled syringe)
ATC code J07BC J07BC
ATC description VIRAL VACCINES VIRAL VACCINES
Reason for shortage Demand increase for the drug. Delay in shipping of the drug.
Anticipated start date
Actual start date 2017-08-08 2017-08-08
Estimated end date 2018-02-09 2018-01-31
Actual end date
Shortage status Actual shortage Actual shortage
Company comments Supply released November 15, 2017 and December 18, 2017 with limited quantity. Supply disruptions may be seen in the private market. Product under allocation. Supply released November 15, 2017 with limited quantity. Supply disruptions may be seen in the private market. Product under allocation.
Health Canada comments